Curebase

Curebase develops an eClinical platform designed to support clinical trials from study startup through database lock. The platform combines ePRO/eCOA, eConsent, participant recruitment, EDC (Electronic Data Capture), participant engagement tools, and AI capabilities into a single integrated system. Curebase serves a range of organizations including small biotechs, pharmaceutical companies, medical device firms, contract research organizations (CROs), and clinical research sites.

The platform is described as AI-powered and is built to help teams launch studies faster, improve data quality, and maintain participant engagement throughout the trial lifecycle. It offers both a site-facing portal and a mobile-first participant application, and is accessible to organizations of varying sizes and structures.

Core Platform Modules

• ePRO/eCOA: Electronic patient-reported outcomes and clinical outcome assessments, enabling remote and decentralized data collection from participants.
• eConsent: Digital informed consent workflows to streamline the consent process for participants and sites.
• Recruitment: Tools to support participant identification and enrollment into clinical studies.
• EDC (Electronic Data Capture): Structured data capture functionality for clinical trial data management.
• Engagement: Features designed to keep participants connected and active throughout the course of a study.
• AI: Artificial intelligence capabilities integrated across the platform to support study operations and data quality.

Site and Participant Experience

• Clinical research sites access a dedicated site portal designed to streamline patient management, automate workflows, and accelerate enrollment.
• Participants interact with a mobile-first app that allows them to complete visits, track their progress, and stay connected with the study team from any location.
• Curebase also operates Sitebase.ai, a separate product offering specifically for research sites.

Target Customer Segments

• Biotech: The platform is positioned for lean, fast-moving teams typical of smaller biotech organizations.
• MedTech: Includes purpose-built tools for running medical device trials.
• Pharma: Supports scaling of global clinical programs on a structured platform.
• CROs: Designed to allow management of multiple sponsors and studies within a single environment.
• Clinical Research Sites: Provides site-specific tooling, including through the Sitebase.ai product.

Platform Reach and Usage

• Curebase reports powering studies at a number of leading organizations, though specific customer names are not listed in the available content.
• Metrics cited on the platform include thousands of participants, thousands of consents signed, millions of data points collected, and a growing number of studies powered.
• An interactive demo is available without requiring sign-up, offered in both a site view and a participant view.

Curebase positions its platform as suitable for organizations ranging from two-person biotechs to global CROs, with the stated goal of reducing study timelines and producing cleaner, more reliable clinical trial data.